Raconteur Global Resources Limited issued a corrigendum to its AGM notice dated 20th August 2026 in response to a query from BSE Listing Centre dated 03rd September 2026. The corrigendum amends disclosures for Resolution No. 7 & 8 related to the preferential issue agenda item for the 8th AGM scheduled for 18th September 2026.

Key Corrections and Additional Disclosures:

1. Pricing Correction:

  • The minimum issue price for the preferential issue has been corrected from ₹12.206 to ₹12.201 per share
  • This price was determined in accordance with Regulation 164(1) of SEBI ICDR Regulations
  • The valuation report was provided by Mr. Sandeep Agarwal, Registered Valuer (IBBI Registration No.: IBBI/RV/06/2020/13344)
  • The actual issue price is set at ₹12.5 per share (including ₹2.5 premium)

2. Fund Utilization Details:

  • Total issue size: ₹30,00,00,000 (Thirty Crore)
  • 75% of proceeds (₹22,50,00,000) will be invested in subsidiary companies Rockbase Real Estate Projects Limited and Skycrest Projects Limited
  • Investment will be made through equity capital contribution or loans within 12 months from receipt
  • Subsidiaries will use funds for real estate project development, IT services, and working capital
  • 25% of proceeds (₹7,50,00,000) allocated for general corporate purposes within 12 months

3. Ultimate Beneficial Ownership Clarification:

  • For individual allottees Yogesh Singh Rana, Abhineet Sapra, Radha Sapra, Sumit Narula, and Srishti Abrol, the natural persons who are ultimate beneficial owners are marked as "Not Applicable"

4. Shareholding Calculation Methodology:

  • Post-preferential issue shareholding percentages are calculated based on total paid-up equity shares of 4,20,27,842
  • This comprises:
  • Existing paid-up equity shares as of 02nd July 2026: 1,32,77,843 shares
  • Equity shares from conversion of outstanding warrants: 47,49,999 shares (1:1 ratio)
  • Equity shares proposed in current preferential issue: 8,00,000 shares
  • Warrants proposed in current issue: 2,32,00,000 warrants (assuming full conversion)

5. Additional Regulatory Disclosures:

  • Confirms no change in control or management of the Company resulting from the preferential issue
  • Confirms compliance with minimum public shareholding requirements
  • Allottees will continue to be classified under Public Category post-allotment

Preferential Issue Details:

Warrants Issue:

  • 2,32,00,000 warrants convertible into equity shares
  • Issue price: ₹12.5 per share (including ₹2.5 premium)
  • Total value: ₹29,00,00,000

Equity Shares Issue:

  • 8,00,000 equity shares
  • Issue price: ₹12.5 per share (including ₹2.5 premium)
  • Total value: ₹1,00,00,000

Allottee Categories:

  • The preferential issue is proposed to Non-Promoters/Public shareholders only
  • No promoters, directors, or key managerial personnel (except Mr. Surinder Kalra through Max Bio Biosciences Private Limited) are participating

Timeline:

  • Allotment to be completed within 15 days from resolution passing date
  • If regulatory approvals pending, allotment within 15 days from last approval receipt

Lock-in Period:

  • Equity shares subject to lock-in as per Regulation 167 of SEBI ICDR Regulations
  • Pre-preferential allotment shareholding locked-in for 90 trading days from relevant date

Shareholding Pattern Impact:

The post-issue shareholding pattern shows significant changes:

  • Promoter holding remains minimal at 0.002% (736 shares)
  • Public shareholding increases to 99.998% from 99.99%
  • Bodies corporate shareholding increases to 76.14% from 60.22%
  • Individual shareholders above ₹2 lakhs increase to 20.15% from 28.02%